626. Aggressive Lymphomas: Epidemiological Excluding Prospective Clinical Trials: Poster III

Comparative analysis of consolidation strategies after induction chemotherapy in primary central nervous system lymphoma

Early mortality and prognostic factors in diffuse large B cell lymphoma presenting with hemophagocytic lymphohistiocytosis

Clinical outcomes associated with conditioning regimens in patients with primary central nervous system lymphoma undergoing consolidation autologous stem cell transplantation

Efficacy and safety of the TEAM conditioning for autologous stem cell transplantation in lymphoma patients with high risk of central nervous system relapse

Clinicopathological characteristics of high grade B cell lymphomas through  Bone marrow evaluation

Inpatient outcomes of diffuse large B cell lymphoma Racial and socioeconomic disparities in a nationally representative sample

Treatment patterns in patients aged 80 years with LBCL Propensity score analysis reveals comparable outcomes between R CHOP and R mini CHOP

Machine learning based immunoinflammatory phenotypes predict survival in Latin American patients with diffuse large B cell lymphoma A multicenter cohort study of grupo de estudio latinoamericano de linfoproliferativos GELL

Development and validation of a novel pathologically based prognostic model for primary central nervous system lymphoma

A US real world analysis of demographics transplant patterns and survival outcomes in posttransplant lymphoproliferative disorder PTLD

Estimating and forecasting the incidence prevalence and counts of treatment eligible patients with diffuse large B cell lymphoma and Mantle Cell Lymphoma in the US

Clinical and pathological features of patients with large B cell lymphoma relapsing after CAR T cell therapy

Shorter diagnosis to treatment interval is associated with poor prognosis in patients with peripheral T cell lymphoma Analysis from the LEO and MER cohorts

Construction of a prognostic model for new diffuse large B cell lymphoma and research on risk factors for secondary central nervous system infiltration

Long term outcomes survival predictors and up front treatment patterns in 568 elderly diffuse large b cell lymphoma patients from LATAM Is R CHOP still the first choice for treating patients older than 60 years

A novel prognostic scoring system incorporating XPO1 for primary central nervous system lymphoma

Treatment patterns and outcomes for large B cell lymphoma patients with central nervous system relapse A multicenter retrospective study CoNSensus Study